US 12213990
A3 adenosine receptor ligand for use for achieving a fat loss effect
granted A61KA61K31/4706A61K31/4745
Quick answer
US patent 12213990 (A3 adenosine receptor ligand for use for achieving a fat loss effect) held by CAN-FITE BIOPHARMA LTD. expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAN-FITE BIOPHARMA LTD.
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/4706, A61K31/4745, A61K31/7076, A61P